Tuesday , December 12 2017
Home / Resources (page 62)



Did You Know: Safety Concerns for Diabetes Medications

When it comes to antidiabetic therapies, professionals should be aware of safety concerns with concentrated insulin formulations, metformin and renal function, and SGLT-2 inhibitors and DKA. See the breakdown of these safety issues by Tom Palma, RPh, MS, BCPS, and Greg Wiggers, PharmD, PhD, plus exclusive commentary by DIC Advisory Board member Dr. George Bakris.

Read More »

Diagnosing Fatty Liver

Test Your Knowledge

When diagnosing suspected nonalcoholic fatty liver disease (NAFLD), hepatic steatosis and inflammation with hepatocellular injury is an indication of which one of the following? A. Nonalcoholic fatty liver (NAFL) B. Nonalcoholic steatohepatitis (NASH) C. Both of the above D. None of the above Follow the link to see the correct answer!

Read More »

International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #72: Regulation of Glucose Metabolism in Liver Part 8 of 11

Linking molecular and metabolic regulation of hepatic glucose metabolism: Cross-talk between metabolism and molecular biology is an emerging mechanism of metabolic regulation and is particularly relevant to the control glucose metabolism in liver. Some transcription factors and nuclear receptors are activated in response to metabolites. During fasting lipid metabolites are released that activate PPARα and induce the gene expression of oxidative metabolism.

Read More »